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Do Smoking and Socioeconomic Factors Influence Imaging 
Outcomes in Axial Spondyloarthritis? Five-Year Data From 
the DESIR Cohort
Elena Nikiphorou,1  Sofia Ramiro,2  Alexandre Sepriano,3  Adeline Ruyssen-Witrand,4  
Robert B. M. Landewé,5 and Désirée van der Heijde6
Objective. To investigate the relationship between smoking and imaging outcomes over 5 years in axial 
spondyloarthritis (SpA) and to assess whether socioeconomic factors influence these relationships.
Methods. Axial SpA patients from the Devenir des Spondylarthropathies Indifferérenciées Récentes cohort were 
included. The following 4 imaging outcomes were assessed by 3 central readers at baseline, 2 years, and 5 years: spine 
radiographs (using the modified Stoke Ankylosing Spondylitis Spine Score [mSASSS]), sacroiliac (SI) joint radiographs 
(using the modified New York criteria), magnetic resonance imaging (MRI) of the spine (using the Spondyloarthritis 
Research Consortium of Canada [SPARCC] score), and MRI of the SI joint (using the SPARCC score). The explanatory 
variable of interest was smoking status at baseline. Interactions between smoking and socioeconomic factors (i.e., 
job type [blue-collar or manual work versus white-collar or nonmanual work] and education [low versus high]) were 
first tested, and if significant, analyses were run using separate strata. Generalized estimating equations models were 
used, with adjustments for confounders.
Results. In total, 406 axial SpA patients were included (52% male, 40% smokers, and 18% blue-collar workers). 
Smoking was independently associated with more MRI-detected SI joint inflammation at each visit over the 5 years, 
an effect that was seen only in patients with blue-collar professions (β = 5.41 [95% confidence interval (95% CI) 1.35, 
9.48]) and in patients with low education levels (β = 2.65 [95% CI 0.42, 4.88]), using separate models. Smoking was 
also significantly associated with spinal inflammation (β = 1.69 [95% CI 0.45, 2.93]) and SI joint damage (β = 0.57 
[95% CI 0.18, 0.96]) across all patients, irrespective of socioeconomic factors and other potential confounders.
Conclusion. Strong associations were found, in particular, between smoking at baseline and MRI-detected SI joint 
inflammation at each visit over a time period of 5 years in axial SpA patients with a blue-collar job or low education level. 
These findings suggest a possible role for mechanical stress amplifying the effect of smoking on axial inflammation in 
axial SpA.
INTRODUCTION
Smoking and systemic inflammation, as measured by 
C-reactive protein (CRP) level or the Ankylosing Spondylitis 
Disease Activity Score (ASDAS) (1), respectively, have been 
shown to independently predict spinal radiographic progression in 
patients with axial spondyloarthritis (SpA) (2,3). At a cross-sectional 
level, using data from the first visit of patients in the Devenir des 
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Spondylarthropathies Indifférenciées Récentes (DESIR) cohort, 
smoking has been shown to be independently associated with 
higher disease activity and increased axial inflammation on mag-
netic resonance imaging (MRI), as well as increased axial structural 
damage noted on MRI and radiographs (4). In a longitudinal anal-
ysis of the Outcome in Ankylosing Spondylitis International Study 
(OASIS) cohort, smoking amplified the effect of disease activity 
on spinal progression, suggesting an indirect effect of smoking 
through inflammation (5). More specifically, for every additional unit 
increase in ASDAS in smokers, there was an increase in the mod-
ified Stoke Ankylosing Spondylitis Spine Score (mSASSS) of 1.9 
units per 2 years, compared to only 0.4 units in nonsmokers (5).
The above-mentioned study was the first to suggest that 
the effect of smoking on radiographic progression was, at least 
in part, driven by higher disease activity. However, the complex 
relationships between smoking, inflammation, and radiographic 
progression have not yet been fully elucidated. In fact, other data 
fail to confirm an association between smoking and structural 
progression (6), highlighting the need to further explore these 
associations.
It has also been argued that certain socioeconomic fac-
tors may play a role. For example, similar to smoking, physically 
demanding jobs are associated with structural damage and have 
been shown to amplify the effect of inflammation on bone for-
mation (5). In the case of axial inflammation on MRI, the longer-
term effects of smoking or socioeconomic factors remain largely 
unknown, with data limited to early axial SpA at baseline (4).
Whether indicators of poor socioeconomic status such as 
physically demanding jobs and smoking lead to worse disease 
outcomes beyond inflammation alone remains to be clearly 
answered. An important challenge is dissociating socioeco-
nomic factors that tend to cluster, for example, dissociating 
smokers from people with physically demanding jobs or lower 
education. This represents a difficult task, especially in analyses 
of “real-life” cohorts where this kind of clustering is unavoid-
able. However, these unmet gaps in the literature highlight the 
need to better understand the intricate relationships between 
smoking, socioeconomic factors, and axial inflammation and 
damage, and therefore to understand how these factors poten-
tially interact with and link to more inflammation and damage. 
We undertook this study to assess the association between 
smoking and imaging outcomes (both inflammation and struc-
tural damage on MRI and conventional radiographs) in axial 
SpA at each visit over a 5-year time period and the potential 
role of socioeconomic factors as effect modifiers or confound-
ers of this association.
PATIENTS AND METHODS
Study population. Consecutive patients (ages 18–50 years) 
with inflammatory back pain lasting ≥3 months but <3 years, 
and with symptoms suggestive of axial SpA according to the 
local investigator’s assessment (e.g., a score of ≥5 on a 0–10 
numerical rating scale [0 nonsuggestive, 10 very suggestive]), 
were recruited across 25 centers in France as part of the pro-
spective, multicenter longitudinal DESIR cohort (ClinicalTrials.
gov identifier: NCT01648907) (7). To be included in this anal-
ysis, patients had to fulfill the Assessment of SpondyloArthritis 
international Society (ASAS) axial SpA classification criteria (8) 
and have at least one imaging outcome available, as well as 
baseline information on smoking and socioeconomic factors. 
Imaging assessments were conducted at baseline, 2 years, and 
5 years. The database used for this analysis was locked in June 
2016.
Ethics approval. The DESIR study was conducted accord-
ing to good clinical practice guidelines and was approved by the 
appropriate local medical ethical committees (Comité de Protec-
tion des Personnes Ile de France III). A detailed description of the 
study protocol is available at the DESIR website (http://www.lacoh 
orted esir.fr/desir-in-engli sh/). The research proposal for this par-
ticular analysis was approved by the scientific committee of the 
DESIR cohort. Written informed consent was obtained from par-
ticipating patients before inclusion.
Imaging outcomes. Plain radiographs were obtained 
at all centers, with MRI scans for follow-up occurring only at 
9 centers in Paris. Four imaging outcomes were used: spine 
radiographs (using the mSASSS, range 0–72) (9), sacroiliac (SI) 
joint radiographs (using modified New York criteria, range 0–8) 
(10), MRI of the spine (using the Spondyloarthritis Research 
Consortium of Canada [SPARCC] score, range 0–414) (11), and 
MRI of the SI joint (using the SPARCC score, range 0–72) (12). 
The mSASSS and modified New York scoring systems meas-
ure the extent of radiographic damage in the spine and SI 
joints, respectively. Specifically, the mSASSS system measures 
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spinal structural damage, with proven validity, feasibility, and 
sensitivity to change in patients with early axial SpA (13), 
whereas the modified New York scoring system is the conven-
tional method for assessing SI joint structural damage on radio-
graphs and consists of a semiquantitative scale from 0 (normal) 
to 4 (total ankylosis) (10). In the present study, the latter was 
scored using a 0–8 scale, combining scores for both SI joints. 
The SPARCC indices measure the presence, depth (3-dimen-
sional extent), and signal intensity of active inflammation repre-
sented by bone marrow edema in the spine and SI joints. Plain 
radiographs and MRIs were scored independently by 3 central 
readers who were blinded with regard to time order (baseline, 
2 years, 5 years), clinical information, and imaging findings from 
other modalities. The average score from all 3 reviewers was 
used as an absolute value.
Smoking and socioeconomic factors. The main inde-
pendent variable of interest was smoking, tested as a binary vari-
able to indicate smoking status (current smoker versus noncurrent 
smoker), recorded at baseline and at every subsequent visit. 
Socioeconomic variables included age, sex, ethnicity, job type, 
educational status, marital status, and parental status (number 
of children). Ethnicity (white versus nonwhite), education status 
(low [non-university] versus high [university]), and marital status 
(married versus unmarried) were used as binary variables in the 
analyses, and parental status (number of children) as a continu-
ous variable. Similarly, job type was based on “collar” profession, 
handled as a binary variable with blue-collar indicating physically 
demanding, manual labor and white-collar indicating sedentary, 
office-based work (14).
Other independent variables of interest, also collected at 
each visit and tested as potential confounders in the analyses, 
included clinical variables (extraarticular manifestations, namely 
uveitis, psoriasis, and inflammatory bowel disease; for all vari-
ables, if once positive, they were treated as always positive in 
subsequent visits), laboratory variables (e.g., CRP level), and 
treatment variables (namely, nonsteroidal antiinflammatory drugs 
[NSAIDs], based on computation of the ASAS NSAID score 
[range 0–400] [15], also tested as a binary variable [NSAID use 
in the last 6 months], conventional synthetic disease-modifying 
antirheumatic drugs [csDMARDs], and tumor necrosis factor 
inhibitor use).
Table 1. Baseline characteristics of the study patients (n = 406)*
Baseline 5 years
Independent variable
Age, years 31.6 ± 7.3 –
Male sex, no. (%) 210 (52) –
Current smoker, no. (%) 162 (40) –
White ethnicity, no. (%) 363 (89) –
Low education level (primary/secondary school), no. (%) 145 (36) –
Blue-collar profession (n = 351), no. (%) 64 (18) –
Married/in couple, no. (%) 251 (62) –
No. of children 0.91 ± 1.1 –
HLA–B27 positive, no. (%) 358 (88) –
Symptom duration, years 1.6 ± 0.9 –
ASDAS-CRP (n = 391) 2.6 ± 1.0 –
CRP, mg/liter (n = 395) 8.5 ± 13.7 –
BASDAI, 0–10 (n = 405) 4.2 ± 2.0 –
BASFI, 0–10 (n = 403) 2.8 ± 2.2 –
History of uveitis, no. (%) 39 (10) –
History of psoriasis, no. (%) 60 (15) –
History of IBD, no. (%) 20 (5) –
History of peripheral arthritis, no. (%) 91 (22) –
NSAID score in past week, 0–400 (n = 397) 61.9 ± 52.3 –
TNFi use, no. (%) 0 (0) –
Imaging outcome
Spine radiograph, mSASSS score, 0–72 
(n = 389 at baseline, n = 251 at 5 years)
0.4 ± 1.7 1.0 ± 3.7
SI joint radiograph, modified New York score, 0–8 
(n = 396 at baseline, n = 269 at 5 years)
1.7 ± 1.8 2.0 ± 2.0
Spine MRI, SPARCC score, 0–414 
(n = 383 at baseline, n = 100 at 5 years)
2.7 ± 8.0 2.2 ± 4.6
SI joint MRI, SPARCC score, 0–72 
(n = 391 at baseline, n = 100 at 5 years)
4.5 ± 7.6 3.1 ± 5.5
* Except where indicated otherwise, values are the mean ± SD. ASDAS-CRP = Ankylosing Spondylitis 
Disease Activity Score using the C-reactive protein level; BASDAI = Bath Ankylosing Spondylitis 
Disease Activity Index; BASFI = Bath Ankylosing Spondylitis Functional Index; IBD = inflammatory 
bowel disease; NSAID = nonsteroidal antiinflammatory drug; TNFi = tumor necrosis factor inhibitor; 
mSASSS = modified Stoke Ankylosing Spondylitis Spine Score; SI = sacroiliac; MRI = magnetic 
resonance imaging; SPARCC = Spondyloarthritis Research Consortium of Canada. 
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Statistical analysis. The relationship between smoking 
status and each imaging outcome was analyzed using sepa-
rate models. The main models were built using independent 
variables at baseline and imaging outcomes at each visit for the 
DESIR cohort (baseline, 2 years, 5 years). A sensitivity analysis 
was undertaken using models built with both independent and 
outcome variables tested at each time point over the course of 
5 years (i.e., “time-varying” analyses). This approach was used 
to better understand the relationship and the strength of the 
relationship between independent and dependent variables at 
each time point. Generalized estimating equations (GEEs) anal-
yses were conducted, making use of repeated observations per 
patient and taking within-patient correlations into account. For 
the latter, the aim was to make use of all data available, allowing 
for both independent (“explanatory”) variables and outcomes to 
vary over time.
First, potential interactions between smoking and socioeco-
nomic factors were investigated and, if statistically (P < 0.15, set a 
priori) and clinically relevant, subsequent analyses were stratified. 
Strata for job type or educational level, respectively, were based 
on whether patients were in a blue-collar profession or not or had 
attained higher education or not, at baseline. Interactions were 
tested for smoking status at baseline. For the sensitivity analyses 
of models built with independent variables and outcomes at each 
time point, strata for job type or education level, respectively, were 
based on whether patients were at any time in a blue-collar pro-
fession (ever blue-collar versus never blue-collar) or had higher 
education (ever higher education versus never higher education) 
over the 5 years of follow-up. Interactions were tested for smoking 
status at each visit. Subsequently, univariable and multivariable 
analyses were undertaken. The significance level for entry in 
to multivariable analyses was set a priori at P < 0.20. Variables 
deemed relevant (e.g., age and sex) were forced into the multi-
variable models. Forward selection was used to choose the best 
final model, keeping in the model variables relevant to explain the 
outcome of interest (P < 0.05) or confounders of the main relation-
ship of interest (e.g., smoking and imaging outcomes). Beta coef-
ficients and 95% confidence intervals (95% CIs) were calculated. 
Stata SE version 14 (StataCorp) was used in all analyses.
RESULTS
A total of 406 patients were included in the present study. 
The mean ± SD age was 31.6 ± 7.3 years, and 52% of the 
patients were male. The baseline sociodemographic and clinical 
characteristics of the patients are summarized in Table 1. Of the 
patients with a blue-collar job (18%), 81% were male, and 70% 
had never attained higher education.
Interaction between smoking and socioeconomic 
factors on imaging outcomes. Significant interactions 
between baseline smoking and job type (P = 0.024) and between 
baseline smoking and education (P = 0.036) on MRI-detected SI 
joint inflammation were identified. Specifically, the effect of smok-
ing observed by assessing MRI-detected SI joint inflammation 
was much stronger in patients who had blue-collar jobs (β = 6.20 
[95% CI 1.54, 10.87]) compared to those with white-collar jobs 
(β = 0.67 [95% CI −0.79, 2.12]), and in those who had a lower 
education level (β = 3.59 [95% CI 0.82, 6.37]) compared to those 
with a higher education level (β = 0.21 [95% CI −1.15, 1.58]) 
Table 2. Association (β [95% confidence interval]) between baseline smoking and imaging outcomes at each visit during 5-year follow-up*
Spine radiograph, 
mSASSS score,  
all patients 
(n = 331)
SI joint radiograph, 
modified New York 
score, all patients 
(n = 328)
Spine MRI, 
SPARCC score,  
all patients 
(n = 377)







Smoking vs. not smoking 0.26 (−0.35, 0.86) 0.57 (0.18, 0.96)† 1.69 (0.45, 2.93)† 5.41 (1.35, 9.48)† 0.24 (−1.13, 1.62)
Age 0.06 (0.01, 0.11)† −0.03 (−0.06, 0.00) 0.07 (−0.03, 0.17) −0.05 (−0.32, 0.21) −0.13 (−0.24, −0.02)
Male vs. female 0.36 (−0.18, 0.89) 0.25 (−0.12, 0.63) 2.39 (1.29, 3.49)† 3.80 (0.15, 7.45)† 2.07 (0.68, 3.47)†
White ethnicity vs. all  
other ethnic groups
‡ −1.03 (−1.75, −0.30)† ‡ ‡ ‡
Blue-collar vs. white-collar 0.70 (−0.13, 1.54)§ 0.75 (0.24, 1.75)† ‡ ‡ ‡
Abnormal vs. normal CRP 
level
0.70 (−0.13, 1.54)§ 1.23 (0.77, 1.69)† 4.29 (2.28, 6.31)† 7.41 (1.90, 12.92)† 3.47 (1.63, 5.31)†
BASDAI (0–10) ‡ −0.16 (−0.25, −0.07)† ‡ −1.08 (−2.16, −0.00)§ −0.27 (−0.66, 0.12)
csDMARD use in last 6 
months vs. not
‡ −0.75 (−1.28, −0.22)† −2.39 (−3.79, −0.99)† −4.29 (−7.54, −1.03)† −2.41 (−4.17, −0.65)†
Presence of uveitis ‡ ‡ −1.97 (−3.24, −0.69)† ‡ ‡
Presence of peripheral 
arthritis
‡ ‡ −2.32 (−3.54, −1.10)† −6.52 (−10.03, −3.00)† −1.67 (−4.09, 0.74)
* Stratified models for SI joint MRI (SPARCC score) are shown due to identified interactions between smoking and job type. Other independent 
variables tested (P > 0.20 in univariable models) include HLA–B27 status, all socioeconomic variables of interest, ASDAS or BASDAI, and presence 
of psoriasis or IBD. csDMARD = conventional synthetic disease-modifying antirheumatic drug (see Table 1 for other definitions). 
† P < 0.05. 
‡ Not significant in multivariable models. 
§ Confounding effect on the association between smoking and the outcome. 
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(Supplementary Table 1, on the Arthritis & Rheumatology website 
at http://onlin elibr ary.wiley.com/doi/10.1002/art.41408/ abstract). 
In sensitivity analyses of time-varying models with both predictors 
and outcomes tested at each time point, interactions between 
smoking and job type, with MRI-detected SI joint inflammation 
and modified New York scores as outcomes, were also identified. 
Similarly, education status also proved to modify the relationship 
between smoking and MRI-detected SI joint inflammation (Sup-
plementary Table 1).
Association between smoking status at baseline 
and imaging outcomes at each time point. Univariable 
analyses are presented in Supplementary Table 2 (http://onlin e 
libr ary.wiley.com/doi/10.1002/art.41408/ abstract). In multivar iable 
models, the effect of smoking (at baseline) was significant for SI 
joint damage, spinal inflammation, and SI joint inflammation at 
each visit during the 5 year time period. For SI joint inflammation, 
the effect of smoking was apparent in those with blue-collar jobs. 
Specifically, a smoker patient with a blue-collar job had 5.41 more 
SPARCC points at each visit compared to a nonsmoker patient with 
a blue-collar job. This effect of smoking was independent of age, 
sex, systemic inflammation (CRP level), or treatment (Table 2 and 
Figure 1). In multivariable models, CRP level and the Bath Anky-
losing Spondylitis Disease Activity Index (BASDAI) (16) were tested 
in different models than the ones that included ASDAS; however, 
only CRP level was significant and thus kept in the final models. 
The effect of smoking on SI joint damage and spinal inflammation 
was also significant.
When the analyses were repeated in separate strata based 
on level of education (higher versus lower education) in view of 
interactions identified between smoking and education, similar 
findings were observed. Smoking was associated with signifi-
cantly higher inflammation in the SI joints in those with lower edu-
cation (β = 2.65 [95% CI 0.42, 4.88]) compared to those with 
higher education (β = 0.36 [95% CI −1.00, 1.71]). This obser-
vation was independent of age, sex, systemic inflammation, and 
treatment (Table 3).
In sensitivity analyses, smoking status at each visit was also 
significantly associated with MRI-detected SI joint inflammation at 
each visit, again only in patients who had blue-collar jobs or lower 
education at any point (Supplementary Tables 3 and 4 and Sup-
plementary Figure 1, http://onlin elibr ary.wiley.com/doi/10.1002/
art.41408/ abstract).
DISCUSSION
The present study, based on 5-year data on axial SpA 
patients from the DESIR cohort, demonstrates associations of 
smoking with structural damage and spinal and SI joint inflam-
mation, the latter exclusively in patients with a blue-collar profes-
sion or a lower education level. The association of smoking with 
inflammation, especially in the pelvis, was much stronger than that 
Figure 1. Effect of baseline smoking on magnetic resonance 
imaging–detected sacroiliac joint inflammation at each visit during 
the 5 years of follow-up in axial spondyloarthritis patients with blue-
collar jobs compared to those with white-collar jobs at baseline. 
Values in parentheses are the 95% confidence interval.
Table 3. Association between baseline smoking and SI joint MRI results (SPARCC score) at each visit, 
in models stratified by level of education*





Smoking vs. not smoking 2.65 (0.42, 4.88)† 0.36 (−1.00, 1.71)
Age 0.05 (−0.09, 0.19) −0.11 (−0.20, −0.02)†
Male vs. female 3.08 (1.27, 4.90)†‡ 1.15 (−0.18, 2.48)
White ethnicity vs. all other ethnic groups −6.17 (−11.08, −1,25)† 0.09 (−2.01, 2.19)
Abnormal vs. normal CRP level 4.45 (1.72, 7.18)† 2.96 (1.13, 4.80)†
BASDAI (0–10) −1.04 (−1.65, −0.43)† −0.38 (−0.74, −0.03)†
csDMARD use in last 6 months vs. not −3.79 (−6.16, −1.43)† −2.63 (−4.36, −0.90)†
* Other independent variables tested in models included HLA–B27 status, all socioeconomic variables 
of interest, ASDAS, presence of psoriasis, IBD, or peripheral arthritis, and use of TNFi. csDMARD = 
conventional synthetic disease-modifying antirheumatic drug (see Table 1 for other definitions). 
† P < 0.05. 
‡ Confounding effect on the association between smoking and the outcome. 
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with structural damage. These relationships are not explained by 
any possible confounders that were assessed, including age, sex, 
systemic inflammation, or treatment.
Our findings confirm the known independent associations 
between smoking, inflammation, and structural damage in early 
axial SpA (4), but they also confirm these for the first time using 
imaging outcomes up to 5 years after diagnosis. These are 
interesting, albeit not fully explained, observations, as are the 
previously observed longitudinal associations between blue-col-
lar work (which entails more mechanical stress) and greater 
inflammation in smokers (5). These observations were made 
irrespective of patient sex, disease activity, disease duration, or 
treatment. Our findings suggest that smoking may amplify the 
effects of inflammation on SI joints in patients with a lower soci-
oeconomic status, as reflected by job type and level of educa-
tion (i.e., blue-collar job and lower education). The clustering of 
specific socioeconomic factors such as job type and education 
level is not surprising, but it is challenging to elucidate. It is cer-
tainly not possible or appropriate to attempt to identify causal 
links, i.e., to determine whether blue-collar jobs cause more 
pelvic inflammation or whether smoking does the same, directly 
or through another factor (residual confounding). Assessing 
whether mechanical stress and cigarette smoking work syner-
gistically to cause inflammation therefore represents a difficult 
task and one that may not be easily accomplished using real-life 
data. Still, our findings support the previously established notion 
of the proinflammatory effects of smoking and their role in inflam-
matory pathways (17–20).
The association of smoking with worse disease outcomes 
is well known, even beyond axial SpA. For example, smoking 
has been associated with worse disease outcomes in rheuma-
toid arthritis through various mechanistic pathways, including 
potentiation of inflammation, oxidative stress, autoantibody for-
mation, and reduced response to treatment (21). This evidence, 
increasingly observed in axial SpA, strengthens the importance of 
encouraging and supporting smoking cessation in patients with 
these diseases, consistent with existing recommendations (22). 
Our findings also support data from animal studies that mechan-
ical strain can directly result in inflammation and new bone for-
mation (23). The study of job type (physically demanding versus 
sedentary) as a proxy for “lifetime mechanical stress” on the spine 
represents a novel approach to better understanding complex 
relationships between important patient and disease parameters 
that may drive worse disease outcomes. Furthermore, our find-
ings on the relationship between smoking and MRI-detected SI 
joint inflammation in models stratified by education align with pre-
vious studies that demonstrated an association between lower 
education and worse disease activity in SpA (24). The findings 
of lower SI joint inflammation with csDMARD use, especially in 
patients with blue-collar professions (and also with the pres-
ence of peripheral arthritis, suggesting less inflammation in those 
patients), may simply reflect a different subtype of axial SpA with a 
predominant peripheral pattern in these patients, combined with 
the use of more csDMARDs (25).
Our findings are clinically meaningful in that they can help 
guide clinicians in the provision of more targeted and patient- 
centric care to axial SpA patients, recognizing those at higher risk, 
whether due to lifestyle parameters or other sociodemographic 
factors. In the larger picture, these observations support the role 
of socioeconomic parameters such as education status and job 
type in explaining differences in health outcomes. More specif-
ically, our results allow us to speculate that indicators of lower 
so cioeconomic status such as job type and lower education have a 
negative effect on health outcomes, demonstrated in this case by 
imaging outcomes in early axial SpA. Perhaps they highlight the 
need for actively educating patients on disease course and man-
agement but also advising, or at least considering, the potential 
impact of a physical job versus a less-physical job in the context of 
axial SpA. It is possible that less educated people are less informed 
and make worse choices when it comes to health and managing 
their disease. One choice could be smoking; another potential 
factor that may be less of a choice is job type. Being aware of 
these factors and their associations can be relevant to routine clin-
ical practice, as they can inform and enable a more holistic and 
individualistic approach to disease management.
Evidence suggests that in patients with axial SpA, disease 
activity and inflammatory lesions on spinal MRI are associated, 
but only in male patients (26). In the present study, patients with 
blue-collar professions were mainly men, which is consistent with 
evidence that supports associations between male sex and higher 
inflammation and structural damage (5,26). In an earlier report on 
the DESIR cohort, smoking was the main association of interest, 
with imaging outcomes (radiographs and MRI) driven by previ-
ous reports of its independent association with higher disease 
activity, axial inflammation on MRI, and axial structural damage 
on MRI and radiographs (4). However, that study focused only 
on cross-sectional analyses of baseline imaging outcomes, unlike 
the present study, which examined relationships with independent 
variables at baseline and imaging outcomes at each visit for up to 
5 years. Sensitivity analyses of independent variables and imaging 
outcomes at each time point confirmed the same associations. 
In this respect, our data are more robust and more informative, 
providing greater insight into these relationships.
There are limitations to our study. First, our findings were 
interpreted on the assumption that blue-collar professions versus 
white-collar professions are representative of high versus low lev-
els of mechanical stress on the spine, respectively. This formed 
the basis for speculation on reasons behind the study findings. 
Although a rather crude dichotomy, it is one that has previously 
been widely accepted and used (5,27). Furthermore, smok-
ing status was the main association of interest in our study, but 
information on the intensity/amount of smoking (e.g., number of 
pack-years) was not available, precluding a more detailed analy-
sis of smoking (and appropriate quantification) and its effects on 
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outcomes. The effect of smoking on spinal inflammation was also 
significant, although not as prominent as for SI joint inflammation. 
Indeed, the interaction between smoking and job type was only 
significant for SI joint inflammation. This may be explained by the 
fact that inflammation at the spine is much lower than at the SI 
joints (28), resulting in a lack of power to detect a significant inter-
action. Finally, it could be argued that the small amount of damage 
present in this cohort of patients with early axial SpA and the lim-
ited imaging changes over time precluded proper investigation of 
the effect of smoking and potentially of socioeconomic factors on 
the damage variables.
Our study has several strengths that also deserve attention. 
Aside from the real-life setting of DESIR and the large patient sam-
ple allowing for the detection of subtle associations between dif-
ferent factors, detailed information on various patient and disease 
characteristics including socioeconomic factors made it possible 
to study these complex relationships. In addition, the inclusion of 
patients with early axial SpA enabled the study of disease predic-
tors and outcomes at crucial early stages of disease. The scoring of 
images by 3 central readers independently and blinded with regard 
to time order (baseline, 2 years, 5 years), with average scores 
used, ensured robust assessment of the imaging outcomes (29).
In conclusion, this study provides new insights into the intri-
cate relationships between smoking, axial damage, and socioeco-
nomic factors in axial SpA. Namely, it was observed that manual 
(blue-collar) jobs and, consequently, mechanical stress amplify the 
effect of smoking on axial inflammation in axial SpA. Not only do 
our findings support the conclusions of translational research, but 
they reinforce the message that further exploration of the pathway 
of mechanical stress and inflammation is relevant and necessary 
in this field. Our study provides greater insight into potential mech-
anistic links between mechanical stress, smoking, and inflamma-
tion. It also suggests the need for more research into this field, 
including investigation of the type and intensity of physical activity 
that may enhance disease progression and lead to adverse out-
comes observed on imaging in axial SpA.
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